| http://www.w3.org/ns/prov#value | - Update of the 2004 guideline was driven mainly by the fact that a further five AEDs had become licensed for use in the UK for the treatment of epilepsy in the intervening years, as well as by the publication of the Standard and New Antiepileptic Drug (SANAD) trial.6Lacosamide is licensed in the UK for adjunctive treatment of refractory focal seizures with or without secondary generalization.
|
